Lenzing's 120 Million Euro Savings Pledge Meets a Wider Nine-Month Loss

Lenzing shares climbed 5.9% after the fiber maker paired its nine-month report with a concrete full-year earnings target, giving investors a firmer number to work with even as the bottom line deteriorated. The advance came on the same day the company reaffirmed plans to strip out EUR 120 million in costs by the end of 2027, measured against a 2025 cost base.

The two announcements tell a single story about a business in mid-overhaul. Management is cutting headcount, closing plants and steering the product mix toward higher-margin specialties, while the accounting cost of that shift lands squarely on reported profit.

Adjusted margin improves, reported figures slip

For the first nine months of 2026, Lenzing posted revenue of EUR 1.93 billion and adjusted EBITDA of EUR 353 million. The adjusted EBITDA margin widened to 18.3% from 17.9% a year earlier — a modest gain achieved despite lower sales, which the company attributes to a stabilization of day-to-day operations.

Reported numbers moved the other way. EBITDA on a reported basis fell to EUR 316.4 million from EUR 340.4 million in the prior-year period, weighed down by EUR 36.6 million in restructuring charges and EUR 136.1 million in non-cash write-downs tied to the Heiligenkreuz and Grimsby sites.

The net loss for the period deepened to EUR 130.3 million from EUR 105 million a year earlier. That gap between the adjusted and reported lines is the crux of the Lenzing case: the underlying margin is inching up, but the price of restructuring is still being paid on the income statement.

Plant closures and 600 job cuts underpin the program

The savings drive goes beyond belt-tightening. Lenzing intends to expand its nonwovens business and sharpen its textile fiber portfolio around premium and specialty products, retreating from low-margin standard fibers to lift earning power. Roughly 600 positions will be eliminated. Production at Heiligenkreuz is scheduled to end by the close of the first quarter of 2027, with Grimsby following by the end of that year.

Medium-term, the company is targeting an EBITDA increase of EUR 150 million, an EBITDA margin of 20–25% and a leverage ratio below 2.5. Those are ambitions, not results — and the restructuring is still weighing on reported earnings before it lifts them.

Capital raise shores up the balance sheet

Financing has become as important a test as the cost program. The capital increase that took effect roughly two weeks ago brought in about EUR 300 million. A further EUR 300 million in financing arrangements is planned, with about half already firmly agreed.

Net financial debt stood at EUR 1,418.9 million at the end of the reporting period. Free cash flow reached EUR 24.7 million, down sharply from EUR 110.9 million a year earlier — a reminder that the operational stabilization has yet to translate into stronger cash generation.

Ownership tilts toward the anchor alliance

On the shareholder side, Lenzing updated its voting-rights figures about a week ago. Following the capital increase, the syndicate of B&C Group and Suzano S.A. held around 52.25% of voting rights, giving the alliance a majority. B&C Group accounted for 39.6% and Suzano International Trade GmbH for 12.6%, according to company disclosures. Suzano Holding S.A. acquired shares equivalent to roughly 0.80% of Lenzing stock in connection with the capital increase, while Goldman Sachs Group was reported at 5.86%.

For the full year 2026, Lenzing expects adjusted EBITDA of EUR 430 million to EUR 460 million. Hitting that range — and converting it into free cash flow — is the yardstick by which the turnaround will be judged.